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doi:10.1016/j.jmii.2011.01.026Background: Primary antibody deficiencies (PADs) are heterogeneous group of disorders, char-
acterized by hypogammaglobulinemia and increased susceptibility to recurrent infections. To
evaluate the diagnostic delay in Iranian PADs in association with their infections, we scored
such manifestations to find an association between such delay and the scoring system.
Methods: Forty-eight patients with PADs, who were referred to our center during a 25-year
period, were enrolled in this study. Each episode of infection, before making the PADs diag-
nosis, got a score of 5 or 10 based on the severity of infections.
Results: The diagnosis was made with median delay of 34.5 months, when the patients had
mean score of 94.48  52.89. There was a significant direct association between this scoring
system and delay diagnosis. The score of 50 was considered as the cutoff point in our patient
group. In this score, the suspicions to PADs in more than 90% of patients true positively lead to
diagnosis of PADs.
Conclusion: Although diagnosis delay significantly decreased over time, PADs still continue to
be diagnosed late. Based on the results of this study, the assessment of immune system should
be performed in the patients with 50 total score or about 25 score per year.
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Primary immunodeficiency diseases (PIDs) are classified into
eight main categories, including (1) combined T- and B-cell
immunodeficiencies; (2) predominantly antibody deficie-
ncies; (3) other well-defined immunodeficiency syndromes;
(4) diseases of immune dysregulation; (5) congenital defects
of phagocyte number, function, or both; (6) defects in innate
immunity; (7) autoinflammatory disorders; and (8) comple-
ment deficiencies.
Predominantly antibody deficiencies (PADs) are hetero-
geneous group of disorders, ranging from a severe reduction
of all serum immunoglobulin isotypes with the absence of B
cells to specific antibody deficiency with normal serum
immunoglobulins.1 PADs are the most common forms of PIDs,
whichconsist ofmore thanhalf of all PIDs.Among thepatients
with PADs, common variable immunodeficiency (CVID), X-
linked agammaglobulinemia (XLA), and Hyper-IgM (HIGM)
syndromes are the predominant symptomatic diseases.2e4
Hypogammaglobulinemia is the main characteristic of
the PADs, which prone the patients to bacterial infections.
The most common infectious complication in patients with
PAD is sinopulmonary infection, caused by Streptococcus
pneumonia, Haemophilus influenza, Klebsiella pneumonia,
and sometimes mycoplasma infections.2,3,5e7 Patients with
PADs also experience gastrointestinal symptoms including
chronic diarrhea and malabsorption.6e10
Early diagnosis and adequate therapy are the keys to
survival and a better quality of life of patients. Regular
immunoglobulin replacement therapy reduces serious
bacterial infections in the patients with XLA11,12 and
CVID,13,14 whereas delays in diagnosis and/or inadequate
management may lead to permanent organ damage such as
bronchiectasis and bronchiolitis obliterans or even death
from overwhelming infections.15e17
It has been shown that diagnosis of antibody deficiency
in patients is associated with considerable delay ranging
from 2.5 to 5 years in children and adults,5e7,18 which is
because of lack of the knowledge about PADs among the
medical community. A few studies were previously been
attempted to score the infectious complications of patients
with PADs to find an association between the patients’
score and suspicious to such diagnosis.15,18,19
To evaluate the diagnostic delay in Iranian PADs in
association with their infections, we scored such manifes-
tations to find an association between such delay and the
scoring system.
Patients and methods
Subjects
Among the patients with PADs, who were referred to Chil-
dren’s Medical Center Hospital, 48 cases were selected as
subjects of this study. They have been referred to this main
referral center for PIDs in Iran during a 25-year period
(1982e2007). The diagnosis of PADs was made based on
standard criteria, introduced by the European Society for
Immunodeficiencies and Pan-American Group for Immuno-
deficiency.20 XLA was confirmed by mutation analysis of
bruton tyrosin kinase gene in agammaglobulinemic malepatients with reduced number of B cells (<1%).9 HIGM was
diagnosed by mutation analysis of CD40 ligand (CD50L),
CD40, and activation-induced cytidine deaminase genes in
the patients with reduced serum levels of IgG and IgA and
normal or elevated IgM level.21 Mutations in the tumor
necrosis factor receptor family member Transmembrane
Activator and calcium-modulating cyclophilin ligand Inter-
actor as well as inducible costimulator and CD19 were also
investigated and only the patients without such genetic
defects were included in this study.22 The diagnosis of CVID
wasmade on the patientswith decreased serum levels of two
ormore IgG, IgM, and IgA, andexclusionof otherwell-defined
single gene defects.1
Scoring system
Diagnosis delay is considered as the duration between the
age of first episode of infection and diagnosis age. Each
episode of infection, before making the PADs diagnosis, got
a score of 5 or 10 based on the severity of disease. Score of
10 was considered for the major infections, including
pneumonia, meningitis, septic arthritis, osteomyelitis, and
severe diarrhea, which need hospitalization (Table 1).
Score of 5 was considered for minor out-patients infections,
including otitis media, sinusitis, and mild diarrhea.18
Statistical analysis
Data analysis was performed using SPSS statistical software
package (version 14.0; SPSS Inc., Chicago, IL, USA). Inde-
pendent samples t testwas performed to compare themeans
between the two groups of patients who were diagnosed
before 1997 and during 1997e2007. Linear regression was
used to determine the association between delay diagnosis
and rate of hospitalization and also delay diagnosis and
scoring system. A p value of less than 0.05 was considered
significant. To evaluate our patients’ score, Receiver Oper-
ating Characteristic (ROC) curve was used. Sensitivity and
specificity for each cutoff point were calculated.
Results
Characteristics of patients
In this study, 48 patients (35 male and 13 female) with
PADs, aged 6 months to 16 years (median: 5 years), were
studied. Among them, 32 patients had CVID (21 male and 11
female), 11 male had XLA, and 5 cases had HIGM (3 male
and 2 female). Thirty patients were from consanguineous
parents (62.5%). There was positive family history of
recurrent infections and early death in 21 families (43.8%).
Infections complications
All the patients presented with infections in different
organs, especially in the respiratory and gastrointestinal
systems, before the diagnosis of PAD. Pneumonia was the
most common manifestations of these patients, which was
seen in 35 patients (73%). Twenty-four cases experienced
episode of sinusitis before diagnosis (50%), whereas
Table 1 The scoring system used in this study
Score 10 Score 5
In-patients severe infections Out-patients mild
infections
Pneumonia Sinusitis
Septic arthritis Diarrhea
Meningitis Otitis media
Osteomyelitis
Serious upper respiratory infection
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(33%) patients, respectively. Six patients experienced
septic arthritis, three patients with meningitis, and one
patient complicated with osteomyelitis.
Diagnosis delay
These PAD patients were diagnosed with a mean delay of
44.58  38.15 months (median: 34.5 months, range: 1
monthe14 years). The diagnosis delay was less than 3 years
in half of these patients, whereas the remaining 24 cases
were diagnosed with a delay of more than 3 years.
Comparison of diagnosis delay between two groups of
patients who were diagnosed before 1997 (30 cases) and
during 1997e2007 (18 cases), indicated that the diagnosis
was made significantly earlier in the recent years
(56.13  41.16 vs. 25.33  22.49, p Z 0.002).
Hospital admission
Infectious complication led to total of 201 hospital admis-
sion during 2,140 months delay of diagnosis. Analysis ofFigure 1. Association between delayhospitalization per patient before diagnosis indicated that
mean hospital admission per patient per year was 2.05.
Statistical analysis of these data was complicated by the
fact that there was a significantly direct association
between delay diagnosis and rate of hospitalization
(R Z 0.579, R2 Z 0.336, F Z 23.24, p < 0.001) (Fig. 1).
Scoring of the infections
Considering the scoring system, which was explained in the
Methods section, the patients had mean score of
94.48  52.89 before the diagnosis was made (median: 80
score, range: 15e275 score). There was a significantly direct
association between this scoring system and delay diagnosis
(R Z 0.856, R2 Z 0.732, F Z 125.59, p < 0.001) (Fig. 2).
Comparison of the scoring of two patient groups, diagnosed
before 1997 (30 cases) and after 1997 (18 cases), showed that
in the years before 1997, the patients gotmore scores before
diagnosis in comparison to the years after 1997
(105.00  58.44 vs. 76.94  37.26, pZ 0.048).
Evaluation of the patients’ score
Figure 3 presents the ROC curve. This procedure is a useful
way to evaluate the performance of classification schemes
in which there is one variable (scores) with two categories
(sensitivity and 1-specificity) by which subjects are classi-
fied. The ROC curve for a test that has some use will lie to
the left of the diagonal of the graph. Depending on the
implications of false positive and false negative results, and
the prevalence of the condition, we can choose the optimal
cutoff for a test, from this graph. The area under the curve
(Z0.84) represents the probability that the assay result for
a randomly chosen positive case will exceed the result fordiagnosis and hospital admission.
Figure 2. Association between delay diagnosis and patients’ score.
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a specific cutoff by which patients are classified and esti-
mate the sensitivity and specificity of the scoring system.
The related table of Fig. 3 reports the sensitivity and 1-
specificity for every possible cutoff for true classificationROC curve
1 - Specificity
Figure 3. Evaluation of the patients’ score.for the diagnosis of PADs. The sensitivity is the proportion
of patients’ classification and with scores greater than the
cutoff. 1-Specificity is the proportion of patients with less
than 3 years delay in diagnosis whose scores are greater
than the cutoff. Cutoff 14 is equivalent to assuming that2,550,000
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Hospitalization in antibody deficiency 233everyone is positively classified. Cutoff 276 is equivalent to
assuming that everyone is negative. Both extremes are
unsatisfactory, and the challenge is to select a cutoff that
properly balances the needs of sensitivity and specificity.
We chose 50 as the cutoff point. In this case sensitivity is 0.9
and 1-specificity is 0.7 (specificity Z 0.3). Therefore more
than 90% of cases are positively classified correctly (Fig. 3).
We have also analyzed the patients’ score per year for the
patients, based on the ROC curve and themean time of delay
diagnosis. Themean score per year, which wasmatchedwith
total score of 50 (sensitivity of 91.7%), was 24.16.Discussion
PADs are a heterogeneous group of rare disorders charac-
terized by decreased serum levels of immunoglobulin iso-
types and increased susceptibility to infections in different
organs, especially in respiratory tract.1,5e9 Considering the
lack of knowledge about PADs among the medical
personnel, the diagnosis of the patients is made with some
delays.3,15,18 Diagnostic delay could lead to a lag for
providing appropriate treatment, resulting to severe
complications and even death in the affected cases.2,3,17
In our study, all the patients experienced episodes of
infections in different organs, with mean score of 94 before
the diagnosis was made. The mean diagnosis delay was more
than 3.5 years (45 months), which is similar to previous
studies.6,18 Such delay significantly decreased over time,
which could be because of an increase of the physicians’
knowledge about such diseases and also better diagnostic
tools available in the recent years.2,3 However, PADs still
continue to be diagnosed late and the diagnosis of many
cases is made after irreversible end-organ damage.2,3,18
All patients with PADs are presented with recurrent
infectious complications. Symptoms that were more likely
to be helpful in considering the diagnosis of PADs in this
study were recurrent infections in the respiratory and
gastrointestinal systems. Although sinopulmonary infec-
tions and diarrhea are the most common manifestations,
septic arthritis, osteomyelitis, and septic meningitis could
also be seen in this group of patients.2,3,23 In fact, early
onset recurrent bacterial infections could suggest PADs,3
which need further evaluation. However, it is not clear
when we should suspect to PADs and which patient should
be further investigated, because some manifestations are
common in healthy subjects as well.19
In this study, we used a scoring system, which had
previously been introduced by Blore and Haeney.18 Using
the score of 10 for the major infections and the score of 5
for minor infections, our patients had mean score of 95
before the diagnosis was made. Statistical analysis of data
indicated this fact that the score of 50 was necessary to
make suspicious for PADs, whereas more than 90% of
patients are positively classified correctly at this score.
However, further evaluation of such scores in non-PADs
subjects is also necessary to evaluate the sensitivity and
specificity of this score. It should also be modified in
different geographical regions.
Considering the patients’ score per year, the ROC curve
for a test will lie to the right of the diagonal of the graph;
so, the ROC curve fails to provide significant values forsensitivity and specificity of the system. However, the
mean score per year of 21 for the patients with delay of
more than 3 years, it could be suggested that the patients
with either two severe infections per year, or one severe
and two minor infections per year could be suspected as
patients with PADs, which needs further evaluation.
Based on the results of this study, the assessment of
immune system should be performed in the patients with
about 25 scoreper year. It shouldbenoted that JefferyModell
Foundation (http://www.jmfworld.com) suggested 10
warning signs for diagnosis of PIDs. Considering some sug-
gested signs, including eight ear infections, two serious sinus
infections, two pneumonias, and two deep-seated infections
within 1 year, amean score of 25 per year is calculated,which
is compatible with resulted score in our study.
A diagnosis delay should be considered in the patients
with total score of 50, whereas the suspicions to PADs at
this score in more than 90% of patients true positively lead
to diagnosis of PADs. The selection of one cutoff point
scores is necessary for primer survey and balance between
usual infections and unusual or over infections. Therefore,
our offered scoring and cutoff 50 seems to be completely
suitable for logical diagnosis and decreased delay in
diagnosis.
Although there are some limitations with such scoring
system, it could provide a useful guide for early diagnosis of
these patients,19 whereas early treatment with immuno-
globulin replacement therapy can decrease the incidence
of recurrent infections and hospitalization in this group of
patients.7,9,12,14,25 Therefore, it is necessary to exclude the
PADs diagnosis in the patients with recurrent infections
even if they did not reach the cutoff point score, whereas
early diagnosis and appropriate management prevent
further complications and improve the quality of life of
these patients.2,3,5,24
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